Nephrocare Health IPO is a Mainboard issue. The company is raising ₹871.05 Crores at a price band of ₹438 - ₹460 per share. One lot is 32 shares.
Nephrocare Health IPO Review & Analysis
Our reading of the numbers below — growth rates, margins, pricing and demand are calculated from the company's own filed figures, not copied from anywhere.
Minimum retail investment
₹14,720
32 shares at the upper band of ₹460
Retail limit
13 lots
the most that fits under the ₹2 lakh retail cap
Total subscription
0.33x
across all categories
GMP-implied listing gain
+8.7%
₹40 premium on a ₹460 issue price
Nephrocare Health is a mainboard issue raising ₹871.05 Crores, offered in a band of ₹438–₹460 per share. At the upper end that is 230 times the ₹2 face value, so ₹458 of every share subscribed is share premium rather than capital.
A retail application for Nephrocare Health needs one lot of 32 shares, which works out to ₹14,720 at the upper band of ₹460. That is close to the ₹15,000 ceiling SEBI expects for a single retail lot, so an investor applying at cut-off is committing nearly the full retail limit per application. Retail applications are capped at ₹2,00,000, which here is 13 lots; bidding above that moves the application into the non-institutional category, and the large-HNI bucket begins at ₹10,00,000, or about 68 lots.
For Nephrocare Health, allotment is finalised on 15 Dec 2025, the shares list on 17 Dec 2025.
Subscription stands at 0.33x, which is below full. An issue must be subscribed at least once over to proceed at all; if it closes under that, the offer is withdrawn and all application money is refunded.
KFin Technologies Pvt. Ltd. is the registrar for this issue, which means the allotment status for Nephrocare Health is published on their portal from 15 Dec 2025. A PAN, application number or demat client ID is enough to look it up; the credited shares also appear in the demat account itself a day or so before listing.
A grey market premium of ₹40 on the upper band of ₹460 implies a listing gain of roughly 8.7%. The grey market is unofficial and unregulated, the premium can change daily, and it has no bearing on allotment — treat it as a sentiment reading, not a forecast.
What to watch
- The issue is only 0.33x subscribed, and an issue that fails to reach full subscription is withdrawn and the money returned.
The figures above are worked out from the issue's own filed numbers and are for information only. They are not investment advice — read the RHP before you apply.
What is Nephrocare Health IPO?
Nephrocare Health IPO is a Mainboard issue. The company is raising ₹871.05 Crores at a price band of ₹438 - ₹460 per share. One lot is 32 shares.
What is the Nephrocare Health IPO price band?
The price band is ₹438 - ₹460 per equity share, against a face value of ₹2. Retail investors may bid at cut-off, meaning they accept the final discovered price within this band.
What is the Nephrocare Health IPO lot size?
The minimum application is 32 shares, and bids must be in multiples of that lot.
What is the Nephrocare Health IPO issue size?
The total issue size is ₹871.05 Crores.
When is the Nephrocare Health IPO allotment date?
Basis of allotment is expected to be finalised on 15 Dec 2025. You can check your status on the registrar's website (KFin Technologies Pvt. Ltd.) using your PAN.
When does Nephrocare Health IPO list?
Listing is expected on 17 Dec 2025, following the T+3 timeline that applies to Indian IPOs.
